Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

A non-randomized, two-arm, single-sequence, crossover, open label, multiple oral dosing clinical trial to evaluate the safety and the pharmacokinetic drug-drug interaction of Telmisartan/Amlodipine and Rosuvastatin in healthy male volunteers

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Daewon Pharmaceutical Co., Ltd.
• Treatments: Amlodipine; Rosuvastatin Calcium; Telmisartan

Criteria

Inclusion Criteria:

• Healthy male who are ≥19, <50 years old

• Man who weights over 55kg and whose BMI is 18~30(kg/m2)

• Man who doesn't have any chronic disease or history of disease

Exclusion Criteria:

• man who has or had any clinically relevant disease of liver, kidney, nervous/respiratory/musculoskeletal/cardiovascular/hemato-oncology system or neuropsychiatry